CN105456710A - Blood-activating and lipid-lowering medicine and preparation method thereof - Google Patents
Blood-activating and lipid-lowering medicine and preparation method thereof Download PDFInfo
- Publication number
- CN105456710A CN105456710A CN201610007752.XA CN201610007752A CN105456710A CN 105456710 A CN105456710 A CN 105456710A CN 201610007752 A CN201610007752 A CN 201610007752A CN 105456710 A CN105456710 A CN 105456710A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood
- fat reducing
- activating
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides a blood-activating and lipid-lowering medicine, and relates to the field of traditional Chinese medicine. The blood-activating and lipid-lowering medicine is mainly prepared from, by weight, 30-60 parts of radix astragali, 10-15 parts of perilla seeds, 10-12 parts of white mustard seeds, 10-20 parts of radish seeds, 10-20 parts of fiveleaf gynostemma herb, 10-15 parts of seaweed, 10-15 parts of kelp, 10-25 parts of raw hawthorn fruits, 10-30 parts of radix polygoni multiflori, 10-20 parts of prepared rhizoma polygonati and 10-15 parts of lucid ganoderma. The blood-activating and lipid-lowering medicine can eliminate phlegm, dispel dampness, dredge collaterals, activate blood and lower lipid, can effectively treat cardiovascular and cerebrovascular diseases, high blood pressure, high blood lipid, diabetes, gout and the like, and is good in treatment effect and high in practicability. The invention further provides a preparation method of the blood-activating and lipid-lowering medicine. The preparation method is easy to implement, and preparation is convenient.
Description
Technical field
The present invention relates to the field of Chinese medicines, in particular to a kind of blood activating and fat reducing medicine and preparation method thereof.
Background technology
Along with the raising of society living standard, rhythm of life is accelerated, and dietary structure changes, and physical exertion such as to gradually reduce at the impact of factors, mankind's numerous disease all presents ascendant trend year by year, as: cardiovascular and cerebrovascular disease, hypertension, hyperlipidemia, diabetes, gout.The method treatment that doctor trained in Western medicine is substantially all taked when treating this type of disease " suit the medicine to the illness, support ", although the medicine utilized can obtain certain therapeutic effect in short-term, but under long-term treatment, along with the enhancing of patient's drug resistance and the appearance of the complication of disease own, the therapeutic effect of these medicines just worse and worse.
Summary of the invention
In view of this, the invention provides a kind of blood activating and fat reducing medicine and preparation method thereof, to improve existing medicine for the poor problem of the therapeutic effect of the disease such as hypertension, hyperlipidemia.
For achieving the above object, the invention provides following technical scheme:
A kind of blood activating and fat reducing medicine, make primarily of following raw material, count by weight: the Radix Astragali 30 ~ 60 parts, Fructus Perillae 10 ~ 15 parts, Semen Sinapis Albae 10 ~ 12 parts, Semen Raphani 10 ~ 20 parts, Herb Gynostemmae Pentaphylli 10 ~ 20 parts, Sargassum 10 ~ 15 parts, Thallus Laminariae (Thallus Eckloniae) 10 ~ 15 parts, Fructus Crataegi 10 ~ 25 parts, Radix Polygoni Multiflori 10 ~ 30 parts, Rhizoma Polygonati (processed) 10 ~ 20 parts and Ganoderma 10 ~ 15 parts.
Relative to prior art, the present invention includes following beneficial effect: when for diseases such as cardiovascular and cerebrovascular disease, hypertension, hyperlipidemia, diabetes, gouts, the traditional Chinese medical science be attributable to " dizzy ", " apoplexy ", " headache due to internal injury ", " obstruction of qi in the chest and cardialgia ", " quenching one's thirst ", the category such as " arthromyodynia ".Morbidity is many caused by factors such as disorder of affect, surfeit delicious food pure wine, easy enjoyment human body phlegm-damp, diseases caused by retention of fluid, stagnation of blood stasis internal organs, meridian qi and blood obstructed caused by, formation focus." Plain Questions logical comments deficiency and excess opinion " section just has: the record of " allly control diseases due to endogenous heat of ZANG FU organs, sudden falling down, hemiplegia, flaccidity with cold limbs, fullness caused by stagnant QI are sent out inverse, fertile high official, then the disease of fat meat and fine grain also ".What " danxi's experiential therapy apoplexy " had again " wet soil raw expectorant, expectorant heat-dissipating, hot air wind producing also " says.
The present invention is exactly according to above-mentioned theory of Chinese medical science, adopts the method for " dehumidifying of eliminating the phlegm, blood circulation promoting and blood stasis dispelling, calming wind and dredging collateral pain relieving " to carry out dialectical treatmert.Through cloud: " the capable then blood of gas, blood wind is from going out "; Cloud " is controlled wind and is first controlled expectorant " again; " Records of Tradition Chinese and Western Medicine in Combination " cloud: " can QI invigorating, doublely can rise gas, kind to control air (i.e. pectoral qi) in the heart sagging ".So reuse the Radix Astragali in composition of raw materials, Radix Astragali sweet in the mouth, tepor, returns spleen lung meridian; Air making-up and spleen enlivening, activating blood and promoting diuresis eliminates the phlegm the gas of dehumidifying, main row the whole body, is monarch drug.The main chemical compositions of the Radix Astragali is glycoside, polysaccharide, flavone, aminoacid, trace element etc., and it can promote organism metabolism, improves anti-fatigue ability; promote the renewal of serum and hepatic protein, have obvious diuresis, can hypoglycemia be raised; reduce hyperglycemia; cardiac contractile force can be strengthened, protection cardiovascular system, arrhythmia; coronary artery dilator and peripheral blood vessel; reduce blood pressure, reduce platelet adhesion power, reduce thrombosis.The Radix Astragali also has obvious blood fat reducing, defying age, anti-hypoxia, radioprotective and hepatoprotective effect.Also add the composition such as Fructus Perillae, Semen Sinapis Albae in raw material, these compositions and the Radix Astragali are worked in coordination with mutually, can strengthen the effect for reducing blood fat of the Radix Astragali, are ministerial drug.The product that Herb Gynostemmae Pentaphylli, Fructus Perillae, Semen Sinapis Albae, Semen Raphani, Sargassum, Thallus Laminariae (Thallus Eckloniae) are dehumidifying of eliminating the phlegm, can promote that the Radix Astragali is played effectiveness, and strengthen the property of medicine effect of blood activating and fat reducing medicine.Modern pharmacological research confirms, Herb Gynostemmae Pentaphylli is containing multiple saponin, saccharide, flavonoid, vitamin C and 18 seed amino acids and multiple inorganic elements etc., Herb Gynostemmae Pentaphylli and gypenoside all have resisting fatigue, anti-hypoxia, high temperature resistance, cryophylactic feature, the life-span of biological cell and fruit bat, mice can be extended, obviously can also increase the function of nonspecific immunity, cellular immunization, humoral immunization, and the obvious blood sugar lowering of tool, effect for reducing blood fat; And the perilla oil that Fructus Perillae extracts has obvious effect for reducing blood fat, its survival rate can be extended to the spontaneous hypertensive rat feeding perilla oil being easy to apoplexy, life span is extended; Semen Sinapis Albae and Semen Raphani have antibacterial, eliminate the phlegm, antitussive, the feature of relievining asthma, can improve urinary function, reduce cholesterol, prevent arteriosclerosis, the extracting solution of Semen Raphani also has and relaxes and the hypotensive effect that continues; Sargassum and Thallus Laminariae (Thallus Eckloniae) contain iodide, have therapeutical effect greatly to the endemic goiter that iodine deficiency causes, in addition, the alginic acid sulfuric acid ester contained in Sargassum, Thallus Laminariae (Thallus Eckloniae) has lipidemia effect, can reduce serum cholesterol and alleviate atherosclerosis, its preserved material also has hypotensive effect; Fructus Crataegi main chemical compositions is triterpene saponin, fatty acid, vitamin C, its energy antiplatelet aggregation, the cholesterol in serum and triglyceride can also be reduced, its effect reducing serum cholesterol and triglyceride is that the excretion increasing cholesterol realizes by improving serum middle-high density cholesterol and subfraction concentration thereof; And Radix Polygoni Multiflori, Rhizoma Polygonati (processed) and Ganoderma are nourishing YIN and benefiting blood promotes the production of body fluid medicine, there is the effect increasing coronary flow and blood pressure lowering, blood fat can be reduced, alleviate Coronary Artery Atherosclerosis, the blood glucose caused adrenal gland is too high also in significant inhibitory action, also has and suppresses adrenocortical effect and antidotal effect.One of gout institute Producing reason is due to Hyperlipemia, hyperlipidemia, metabolism is slow, the uric acid produced in body is greater than the uric acid of discharge, cause caused by uric acid heaps in vivo, and said medicine is by the effect of self blood fat reducing, diuresis, just obviously can reduces uric acid in blood content, effectively treat gout.
In the present invention, monarch drug and ministerial drug cooperatively interact, and play good synergism, fundamentally play a role from body, effect a permanent cure but not take stopgap measures, air making-up and spleen enlivening, blood activating and fat reducing, and conditioning energy and blood of human body, practicality is high, suitable for large-scale promotion.
Preferably, in above-mentioned blood activating and fat reducing medicine, described raw material also comprises Ramulus Cinnamomi 10 ~ 15 parts and Radix Curcumae 10 ~ 12 parts.Ramulus Cinnamomi warming the meridian for promoting the flow of YANG QI, promoting flow of QI and blood is ministerial drug, helps the merit of Radix Astragali promoting flow of QI and blood.Modern pharmacological research confirms: Ramulus Cinnamomi has the effect such as diuresis, heart tonifying, and Radix Curcumae and decoct can reduce whole blood viscosity, anticoagulant, and its ethanol extract can reduce plasma fibrin content.
Preferably, in above-mentioned blood activating and fat reducing medicine, described raw material also comprises Hirudo 6 ~ 10 parts, Radix Angelicae Sinensis 10 ~ 20 parts, Folium Ginkgo 10 ~ 15 parts, Rhizoma Chuanxiong 10 ~ 15 parts, Radix Salviae Miltiorrhizae 10 ~ 30 parts, 10 ~ 15 parts, Rhizoma Curcumae Longae, Lignum Sappan 10 ~ 12 parts, Rhizoma Corydalis Decumbentis 10 ~ 15 parts.These compositions are adjuvant drug, can dredge internal organs, meridian qi and blood.Confirm according to modern pharmacological research: the hirudin in Hirudo has obvious inhibitory action to platelet aggregation, suppress rat thrombus in vivo to be formed, have good therapeutical effect to disseminated inravascular coagulation, hirudin also has inhibitory action to tumor cell.Radix Angelicae Sinensis, Folium Ginkgo, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Rhizoma Curcumae Longae, Lignum Sappan, Rhizoma Corydalis Decumbentis can coronary artery dilating, increases coronary flow, improves myocardial ischemia, can improve hypoxia-bearing capability, can improve microcirculation, promotes velocity of blood flow, can blood vessel dilating, reduces blood pressure.
Preferably, in above-mentioned blood activating and fat reducing medicine, described raw material also comprises Pheretima 10 ~ 12 parts, Formica fusca powder 10 ~ 12 parts, Concha Haliotidis 10 ~ 30 parts, Herba Apocyni veneti 10 ~ 15 parts, Radix Stephaniae Tetrandrae 10 ~ 15 parts.These compositions are adjuvant drug, play the effect of calming wind and dredging collateral pain relieving in whole medicine.Modern pharmacological research confirms: Pheretima, Formica fusca powder all have slow and lasting hypotensive effect, and its extract has fibrinolytic and anticoagulation; In Concha Haliotidis, the clotting assay of acidic extraction liquid to rabbit inside and outside shows, it has significant anticoagulation; Herba Apocyni veneti, Radix Stephaniae Tetrandrae decoct have hypotensive effect, and have the effect of stronger diuresis, reduction blood fat, immunity moderation.
Preferably, in above-mentioned blood activating and fat reducing medicine, described raw material also comprises Radix Puerariae 10 ~ 30 parts.Puerarin in Radix Puerariae can resist the acute myocardial ischemia that pituitrin causes; Radix Puerariae total flavones energy dilating coronary blood vessel and cerebrovascular increase coronary flow and cerebral blood flow, reduce heart oxygen consumption, increase oxygen supply.
Preferably, in above-mentioned blood activating and fat reducing medicine, described raw material also comprises 6 ~ 10 parts, Radix Glycyrrhizae.Radix Glycyrrhizae, can coordinating the actions of various ingredients in a prescription for making medicine.Modern pharmacological research confirms: Radix Glycyrrhizae has antiarrhythmic effect, also has diuresis, blood fat reducing, the effect such as to protect the liver.
Present invention also offers a kind of preparation method of above-mentioned blood activating and fat reducing medicine, according to formula, by all raw material mixed grindings, make powder.
Namely material composition grinding be can be made into powder, take for patient, simple to operate, easy to make.The therapeutic effect of obtained blood activating and fat reducing medicine might as well.
Preferably, in the preparation method of above-mentioned blood activating and fat reducing medicine, the method for described mixed grinding is: mixed by all raw materials, and being ground to particle diameter is more than 80 orders.The requirement of this particle diameter is the consideration of taking assimilation effect based on human body, also meets the regulation of " Chinese Pharmacopoeia " simultaneously.
Preferably, in the preparation method of above-mentioned blood activating and fat reducing medicine, the environmental condition of described grinding is: humidity index is less than 30%.In the preparation process of this medicine, considerably less to the requirement of environment.So, by this medicinal application in suitability for industrialized production, its cost is also lower; And for individual, after also can buying raw material, oneself make and take, easy to operate.For the requirement of ambient humidity, can effectively avoid in process of lapping, air humidity be excessive and cause raw mill to become paste.
Preferably, in the preparation method of above-mentioned blood activating and fat reducing medicine, before described raw material mixed grinding, also comprise pretreatment: described raw material is cleaned, dried.Pretreatment can obtain the considerably less raw material of cleaning, water content, so, advantageously in raw material powder process.
In the present invention, in the process of mixed grinding, require to carry out under pollution-free, clean and tidy environment.
Whole powder of powder all can cross No. five sieves (80 order), and the fine powder of 95% can cross No. six sieves (100 order).
The instructions of taking of the blood activating and fat reducing medicine of powder is: every day three times, took in one hour after the meal, each 6 ~ 10g, take with warm water or Chinese liquor, take continuously and be a course for the treatment of January.
Disease is seen clinically: " vertigo, distending pain in the head, flushed complexion, disposition agitation, dry throat and mouth, cardiopalmus, discomfort uncomfortable in chest; numb limbs and tense tendons is meciless; swelling pain, causalgia, body of the tongue are livid purple, greasy fur, stringy and rolling pulse " person, blood activating and fat reducing medicine provided by the invention all can be utilized to treat.
Western medicine diagnose is: cerebral infarction or cerebral blood supply insufficiency, heart blood supply insufficiency, the diseases such as hypertension, hyperlipidemia, diabetes, gout, belong to " blood-stasis internal-depression, phlegm-damp resistance network person " through differential diagnosis in tcm, use blood activating and fat reducing medicine provided by the invention to treat, therapeutic effect is rather good.
Discuss and pharmacological action analysis:
Blood activating and fat reducing medicine provided by the invention aims at the disease such as cerebral infarction that modern suffers from or the heart, cerebral blood supply insufficiency, hypertension, hyperlipidemia, diabetes, gout and creates.As long as differential diagnosis in tcm belongs to " blood-stasis internal-depression, phlegm-damp resistance network person " this medicine all can be used to treat clinically.Because above-mentioned disease belongs to long-term, intractable chronic disease more, so need are long-term, persistence is taken medicine, so, guarantee reaches the therapeutic effect of expection.So, selecting that the traditional Chinese medical science, Chinese medicine tradition is loose, on ball, cream, pellet form, selected powder preparation formulation, object be convenient to that medicine is long-term for patient, effective absorption and play the therapeutical effect continued.
Compared with prior art, beneficial effect of the present invention is:
(1) good drug efficacy, can effectively treat the diseases such as cardiovascular and cerebrovascular disease, hypertension, hyperlipidemia, diabetes, gout;
(2) regulate from body at all, effect a permanent cure but not take stopgap measures.
Detailed description of the invention
Below in conjunction with embodiment, embodiment of the present invention are described in detail, but it will be understood to those of skill in the art that the following example only for illustration of the present invention, and should not be considered as limiting the scope of the invention.Unreceipted actual conditions person in embodiment, the condition of conveniently conditioned disjunction manufacturer suggestion is carried out.Agents useful for same or the unreceipted production firm person of instrument, be and can buy by commercially available the conventional products obtained.
Embodiment one
Embodiments of the invention one provide a kind of blood activating and fat reducing medicine, make primarily of following raw material, count by weight: the Radix Astragali 30 parts, Fructus Perillae 10 parts, Semen Sinapis Albae 10 parts, Semen Raphani 10 parts, Herb Gynostemmae Pentaphylli 10 parts, Sargassum 10 parts, Thallus Laminariae (Thallus Eckloniae) 10 parts, Fructus Crataegi 10 parts, Radix Polygoni Multiflori 10 parts, Rhizoma Polygonati (processed) 10 parts and Ganoderma 10 parts.
The present embodiment additionally provides a kind of preparation method of above-mentioned blood activating and fat reducing medicine, according to formula, is 80 orders, makes powder by all raw material mixed grindings to particle diameter.
The instructions of taking of the blood activating and fat reducing medicine of the powder preparation formulation that the present embodiment provides is: daily three times, took in one hour after the meal, each 6g, takes with Chinese liquor.
Embodiment two
Embodiments of the invention two provide a kind of blood activating and fat reducing medicine, make primarily of following raw material, count by weight: the Radix Astragali 60 parts, Fructus Perillae 15 parts, Semen Sinapis Albae 12 parts, Semen Raphani 20 parts, Herb Gynostemmae Pentaphylli 20 parts, Sargassum 15 parts, Thallus Laminariae (Thallus Eckloniae) 15 parts, Fructus Crataegi 25 parts, Radix Polygoni Multiflori 30 parts, Rhizoma Polygonati (processed) 20 parts, Ganoderma 15 parts, Ramulus Cinnamomi 15 parts, Radix Curcumae 12 parts, Hirudo 10 parts, Radix Angelicae Sinensis 20 parts, Folium Ginkgo 15 parts, Rhizoma Chuanxiong 15 parts, Radix Salviae Miltiorrhizae 30 parts, 15 parts, Rhizoma Curcumae Longae, Lignum Sappan 12 parts, Rhizoma Corydalis Decumbentis 15 parts.
The present embodiment additionally provides a kind of preparation method of above-mentioned blood activating and fat reducing medicine, comprises the following steps:
A. all raw materials are put into pot, add water, the volume of water accounts for 65% of pot internal volume;
B. pot is heated, decoct raw medicinal material, until decocting 1.5h after solution boiling in pot, then filtering, pouring out decoction liquor;
Again add water in pot, the volume of water accounts for 50% of pot internal volume, continues to decoct 0.5h, filter, pour out decoction liquor after solution boiling in pot, and the decoction liquor mixing of pouring out twice, obtains mixing decoction liquor;
C. will mix decoction liquor to dry, and the mixture after drying is crushed to 100 orders, be then mixed into corn starch, Chinese medicinal tablet made by tabletting.
Take the Chinese medicinal tablet that this law is obtained, taken three times a day, each 10g, Ying Shui swallow.
Embodiment three
Embodiments of the invention three provide a kind of blood activating and fat reducing medicine, make primarily of following raw material, count by weight: the Radix Astragali 38 parts, Fructus Perillae 12 parts, Semen Sinapis Albae 11 parts, Semen Raphani 14 parts, Herb Gynostemmae Pentaphylli 14 parts, Sargassum 12 parts, Thallus Laminariae (Thallus Eckloniae) 12 parts, Fructus Crataegi 17 parts, Radix Polygoni Multiflori 19 parts, Rhizoma Polygonati (processed) 15 parts, Ganoderma 12 parts, Ramulus Cinnamomi 10 parts, Radix Curcumae 10 parts, Hirudo 6 parts, Radix Angelicae Sinensis 10 parts, Folium Ginkgo 10 parts, Rhizoma Chuanxiong 10 parts, Radix Salviae Miltiorrhizae 10 parts, 10 parts, Rhizoma Curcumae Longae, Lignum Sappan 10 parts, Rhizoma Corydalis Decumbentis 10 parts and 6 parts, Radix Glycyrrhizae.
The present embodiment additionally provides a kind of preparation method of above-mentioned blood activating and fat reducing medicine, comprises the following steps:
A. raw material all cleaned, dry;
B. mixed by raw material, grind under being the condition of 30% at room temperature, humidity index, the powder that grinding is obtained all can cross No. five sieves, and the fine powder of 95% can cross No. six sieves, obtained powder.
Take the powder that this law is obtained, every day three times, took in one hour after the meal, each 7g, takes with warm water.
Embodiment four
Embodiments of the invention four provide a kind of blood activating and fat reducing medicine, make primarily of following raw material, count by weight: the Radix Astragali 45 parts, Fructus Perillae 12 parts, Semen Sinapis Albae 11 parts, Semen Raphani 15 parts, Herb Gynostemmae Pentaphylli 15 parts, Sargassum 13 parts, Thallus Laminariae (Thallus Eckloniae) 13 parts, Fructus Crataegi 18 parts, Radix Polygoni Multiflori 20 parts, Rhizoma Polygonati (processed) 15 parts, Ganoderma 12.5 parts, Ramulus Cinnamomi 12 parts, Radix Curcumae 11 parts, Hirudo 8 parts, Radix Angelicae Sinensis 15 parts, Folium Ginkgo 13.5 parts, Rhizoma Chuanxiong 12.5 parts, Radix Salviae Miltiorrhizae 20 parts, 12 parts, Rhizoma Curcumae Longae, Lignum Sappan 11 parts, Rhizoma Corydalis Decumbentis 13 parts, Pheretima 11 parts, Formica fusca powder 11 parts, Concha Haliotidis 20 parts, Herba Apocyni veneti 13 parts, Radix Stephaniae Tetrandrae 13 parts, Radix Puerariae 20 parts and 7.5 parts, Radix Glycyrrhizae.
The present embodiment additionally provides a kind of preparation method of above-mentioned blood activating and fat reducing medicine, comprises the following steps:
A. raw material all cleaned, dry;
B. mixed by raw material, in clean, clean and tidy environment, grind under being the condition of 30% in room temperature, humidity index, the powder that grinding is obtained all can cross No. five sieves, and the fine powder of 95% can cross No. six sieves, obtained powder.
Take the powder that this law is obtained, every day three times, took in one hour after the meal, each 8g, takes with warm water.
The guiding theory of this medicine is: based on the traditional Chinese medical science " organic conception ", " dialectical treatmert ", be used for researching and developing in conjunction with modern pharmacology again, although full presciption medicine taste is on the high side, but it is many and do not mix, medicine at Fang Zhongjun, minister, help, make distinct, Each performs its own functions, common effect of synthesizing eliminate the phlegm dehumidifying, blood circulation promoting and blood stasis dispelling, calming wind and dredging collateral pain relieving.The clinical practice of blood activating and fat reducing medicine through researcher many decades and the clinical observation on the therapeutic effect of hundreds of routine patient, it is at treatment cerebral infarction or cerebral blood supply insufficiency, and heart blood supply insufficiency is in the diseases such as hypertension, hyperlipidemia, diabetes, gout, evident in efficacy.
The blood activating and fat reducing medicine that the present embodiment provides also recorded clinical experiment.In the clinical practice using blood activating and fat reducing medicine treatment hyperlipidemia, hypertension and cardiovascular and cerebrovascular disease, respectively select 50 routine cases and use comparatively general " XUEZHIKANG JIAONANG " of being produced by Wei Xin pharmaceutical Co. Ltd of Beijing Beijing University to make comparisons at present and analyze, result shows that every data of the blood activating and fat reducing medicine treatment that the present embodiment provides all are better than " XUEZHIKANG JIAONANG ", is now summarized as follows:
XUEZHIKANG JIAONANG basic situation:
Composition: Monas cuspurpureus Went
Function cures mainly: blood circulation promoting and blood stasis dispelling, strengthening the spleen to promote digestion.For the hyperlipemia caused by stagnation of phlegm blood stasis, disease sees shortness of breath and fatigue, and dizziness headache, abdominal distention uncomfortable in chest, lack of appetite are indigestion and loss of appetite, also can be used for the auxiliary treatment of other cardiovascular and cerebrovascular disease caused by hyperlipemia and atherosclerosis.
[operative norm] " Chinese Pharmacopoeia " version second enlarged edition in 2010
The accurate word Z10950029 of [authentication code] traditional Chinese medicines
Efficacy result:
(1) hyperlipidemia is treated:
Cure in the loose 50 routine cases of blood activating and fat reducing: 30 examples; Effective: 8 examples; Take a turn for the better: 10 examples; Invalid: 2 examples.
Cure in the routine case of XUEZHIKANG JIAONANG 50: 10 examples; Effective: 15 examples; Take a turn for the better: 18 examples; Invalid: 7 examples.
(2) hypertension is treated:
Cure in the loose 50 routine cases of blood activating and fat reducing: 12 examples; Effective: 28 examples; Take a turn for the better: 6 examples; Invalid: 4 examples.
Cure in the routine case of XUEZHIKANG JIAONANG 50: 5 examples; Effective: 12 examples; Take a turn for the better: 17 examples; Invalid: 16 examples.
(3) cerebral infarction is treated:
Cure in the loose 50 routine cases of blood activating and fat reducing: 8 examples; Effective: 28 examples; Take a turn for the better: 10 examples; Invalid: 4 examples.
Cure in the routine case of XUEZHIKANG JIAONANG 50: 2 examples; Effective: 12 examples; Take a turn for the better: 15 examples; Invalid: 21 examples.
Efficacy analysis:
XUEZHIKANG JIAONANG prescription is single, only has certain therapeutic effect to hyperlipemia, may also have certain auxiliary therapeutic action in addition for because of the atherosclerosis caused by hyperlipidemia, cerebrovascular disease.And the blood activating and fat reducing medicine that the present embodiment provides on prescription special focus on emphasizing modern medical diagnosis " hyperlipidemia ", " hypertension " and other cardiovascular and cerebrovascular disease mostly all because of caused by " phlegm-damp ", " diseases caused by retention of fluid " " blood stasis ".So selected the product of dehumidifying of eliminating the phlegm, phlegm reduction of blood circulation promoting, calming wind and dredging collateral pain relieving on traditional Chinese medical science Selection drug in conjunction with modern pharmacological research analysis, the guideline of traditional Chinese medical science organic conception and dialectical treatmert is really embodied in full side, by clinical practice Ureteral Calculus for many years, achieve very satisfied therapeutic effect.
To sum up, the blood activating and fat reducing medicine that the present embodiment provides effectively can treat the disease such as cardiovascular and cerebrovascular disease and apoplexy, facial paralysis, hypertension, hyperlipidemia, diabetes, gout, and practicality is high, and therapeutic effect is good.
In addition, the blood activating and fat reducing medicine other embodiment provided is used for the disease such as cardiovascular and cerebrovascular disease and apoplexy, facial paralysis, treatment hypertension, hyperlipidemia, diabetes, gout, and the effect of acquisition is consistent with above-mentioned result of the test.
The foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, for a person skilled in the art, the present invention can have various modifications and variations.Within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (10)
1. a blood activating and fat reducing medicine, it is characterized in that, make primarily of following raw material, count by weight: the Radix Astragali 30 ~ 60 parts, Fructus Perillae 10 ~ 15 parts, Semen Sinapis Albae 10 ~ 12 parts, Semen Raphani 10 ~ 20 parts, Herb Gynostemmae Pentaphylli 10 ~ 20 parts, Sargassum 10 ~ 15 parts, Thallus Laminariae (Thallus Eckloniae) 10 ~ 15 parts, Fructus Crataegi 10 ~ 25 parts, Radix Polygoni Multiflori 10 ~ 30 parts, Rhizoma Polygonati (processed) 10 ~ 20 parts and Ganoderma 10 ~ 15 parts.
2. blood activating and fat reducing medicine according to claim 1, is characterized in that, described raw material also comprises Ramulus Cinnamomi 10 ~ 15 parts and Radix Curcumae 10 ~ 12 parts.
3. blood activating and fat reducing medicine according to claim 1, it is characterized in that, described raw material also comprises Hirudo 6 ~ 10 parts, Radix Angelicae Sinensis 10 ~ 20 parts, Folium Ginkgo 10 ~ 15 parts, Rhizoma Chuanxiong 10 ~ 15 parts, Radix Salviae Miltiorrhizae 10 ~ 30 parts, 10 ~ 15 parts, Rhizoma Curcumae Longae, Lignum Sappan 10 ~ 12 parts, Rhizoma Corydalis Decumbentis 10 ~ 15 parts.
4. blood activating and fat reducing medicine according to claim 1, is characterized in that, described raw material also comprises Pheretima 10 ~ 12 parts, Formica fusca powder 10 ~ 12 parts, Concha Haliotidis 10 ~ 30 parts, Herba Apocyni veneti 10 ~ 15 parts, Radix Stephaniae Tetrandrae 10 ~ 15 parts.
5. blood activating and fat reducing medicine according to claim 1, is characterized in that, described raw material also comprises Radix Puerariae 10 ~ 30 parts.
6. blood activating and fat reducing medicine according to claim 1, is characterized in that, described raw material also comprises 6 ~ 10 parts, Radix Glycyrrhizae.
7. a preparation method for the blood activating and fat reducing medicine described in any one of claim 1 ~ 6, is characterized in that, according to formula, by all raw material mixed grindings, makes powder.
8. blood activating and fat reducing medicine according to claim 7, is characterized in that, the method for described mixed grinding is: mixed by all raw materials, and being ground to particle diameter is more than 80 orders.
9. blood activating and fat reducing medicine according to claim 7, is characterized in that, the environmental condition of described grinding is: humidity index is less than 30%.
10. blood activating and fat reducing medicine according to claim 7, is characterized in that, before described raw material mixed grinding, also comprises pretreatment: described raw material is cleaned, dried.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610007752.XA CN105456710B (en) | 2016-01-07 | 2016-01-07 | A kind of blood activating and fat reducing medicine and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610007752.XA CN105456710B (en) | 2016-01-07 | 2016-01-07 | A kind of blood activating and fat reducing medicine and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105456710A true CN105456710A (en) | 2016-04-06 |
| CN105456710B CN105456710B (en) | 2017-11-21 |
Family
ID=55595166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610007752.XA Expired - Fee Related CN105456710B (en) | 2016-01-07 | 2016-01-07 | A kind of blood activating and fat reducing medicine and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105456710B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105999054A (en) * | 2016-05-24 | 2016-10-12 | 辽宁佰福药业有限公司 | Rose diet tea prepared from medical juice and preparation method of rose diet tea |
| CN107441281A (en) * | 2017-08-04 | 2017-12-08 | 绿都中草药研发中心（北京）有限公司 | A kind of diabetes integrate compound preparation |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101987188A (en) * | 2010-11-19 | 2011-03-23 | 何明华 | Biological Chinese patent drug for preventing and treating hyperlipoidemia |
| CN102145128A (en) * | 2011-03-30 | 2011-08-10 | 呼伦贝尔松鹿制药有限公司 | Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof |
| CN102631655A (en) * | 2012-04-05 | 2012-08-15 | 徐学军 | Medicine for treating coronary heart disease and preparation method for medicine |
-
2016
- 2016-01-07 CN CN201610007752.XA patent/CN105456710B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101987188A (en) * | 2010-11-19 | 2011-03-23 | 何明华 | Biological Chinese patent drug for preventing and treating hyperlipoidemia |
| CN102145128A (en) * | 2011-03-30 | 2011-08-10 | 呼伦贝尔松鹿制药有限公司 | Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof |
| CN102631655A (en) * | 2012-04-05 | 2012-08-15 | 徐学军 | Medicine for treating coronary heart disease and preparation method for medicine |
Non-Patent Citations (3)
| Title |
|---|
| 屠庆祝等: "《中药治疗高脂血症的用药规律》", 《山东中医杂志》 * |
| 彭铭泉: "蚂蚁药膳", 《药膳食疗》 * |
| 李明: "《中药降血脂作用机制的研究进展》", 《实用心脑肺血管病杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105999054A (en) * | 2016-05-24 | 2016-10-12 | 辽宁佰福药业有限公司 | Rose diet tea prepared from medical juice and preparation method of rose diet tea |
| CN107441281A (en) * | 2017-08-04 | 2017-12-08 | 绿都中草药研发中心（北京）有限公司 | A kind of diabetes integrate compound preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105456710B (en) | 2017-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101485830B (en) | Pure Chinese medicine anti-aging health-care capsule | |
| CN101972395B (en) | Calming and decompressing traditional Chinese medicine composition and preparation method thereof | |
| CN102172385B (en) | A kind of Chinese medicine preparation with enhancing immunity, blood sugar lowering and effect for reducing blood fat | |
| CN103071128A (en) | Externally-applied plaster for curing dysmenorrhea | |
| CN103301413A (en) | Traditional Chinese medicine composition for treating hyperlipemia and hyperglycemia | |
| CN103341049A (en) | Dendrobium huoshanense-containing traditional Chinese medicine composition with anti-fatigue effect, and preparation method thereof | |
| CN101199672A (en) | Chinese medicine health care wine containing function of regulating human body immunity | |
| CN102631538B (en) | Traditional Chinese medicine for treating heart disease | |
| CN105456710B (en) | A kind of blood activating and fat reducing medicine and preparation method thereof | |
| CN101721608B (en) | Chinese herbal medicine pill used for treating heart diseases | |
| CN101249255B (en) | Proprietary Chinese medicine for curing children's cough and method of preparing the same | |
| CN104173957A (en) | Anti-senile life-prolonging plaster | |
| CN101095798B (en) | Chinese traditional medicine for treating canities | |
| CN103182008A (en) | Preparation method for traditional Chinese medicine used for stabilizing and reducing blood pressure | |
| CN103725587A (en) | Sealwort and hawthorn vinegar and production method thereof | |
| CN101313994A (en) | Traditional Chinese medicine capsule for treating auricular fibrillation | |
| CN103550505A (en) | Traditional Chinese medicine preparation for treating qi-yin deficiency type diabetes | |
| CN103536849A (en) | Drug for treating pulmonary embolism and preparation method thereof | |
| CN103768381B (en) | 18 taste life lengthening balls | |
| CN106334065A (en) | Edible and medicinal traditional Chinese medicine formula used for treating gynecological diseases and having beauty effect and production process | |
| CN101293067A (en) | Capsule for coronary disease | |
| CN101987188B (en) | Biological Chinese patent drug for preventing and treating hyperlipoidemia | |
| CN101181505A (en) | Chinese medicine prescription for cardiac disease as well as manufacturing method | |
| CN114588228B (en) | Composition for treating type 2 diabetes | |
| CN107898968A (en) | Chinese medicinal preparation method with health-care effect |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171121 Termination date: 20220107 |